Cited 0 times in Scipus Cited Count

Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration

DC Field Value Language
dc.contributor.authorKim, H-
dc.contributor.authorShin, JY-
dc.contributor.authorJo, A-
dc.contributor.authorKim, JH-
dc.contributor.authorPark, S-
dc.contributor.authorChoi, JY-
dc.contributor.authorKang, HC-
dc.contributor.authorDawson, VL-
dc.contributor.authorDawson, TM-
dc.contributor.authorShin, JH-
dc.contributor.authorLee, Y-
dc.date.accessioned2023-01-10T00:39:17Z-
dc.date.available2023-01-10T00:39:17Z-
dc.date.issued2021-
dc.identifier.issn0006-8950-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/23930-
dc.description.abstractAberrant activation of the non-receptor kinase c-Abl is implicated in the development of pathogenic hallmarks of Parkinson's disease, such as α-synuclein aggregation and progressive neuronal loss. c-Abl-mediated phosphorylation and inhibition of parkin ligase function lead to accumulation of parkin interacting substrate (PARIS) that mediates α-synuclein pathology-initiated dopaminergic neurodegeneration. Here we show that, in addition to PARIS accumulation, c-Abl phosphorylation of PARIS is required for PARIS-induced cytotoxicity. c-Abl-mediated phosphorylation of PARIS at Y137 (within the Krüppel-associated box domain) drives its association with KAP1 and the repression of genes with diverse functions in pathways such as chromatin remodelling and p53-dependent cell death. One phosphorylation-dependent PARIS target, MDM4 (a p53 inhibitor that associates with MDM2; also known as MDMX), is transcriptionally repressed in a histone deacetylase-dependent manner via PARIS binding to insulin response sequence motifs within the MDM4 promoter. Virally induced PARIS transgenic mice develop c-Abl activity-dependent Parkinson's disease features such as motor deficits, dopaminergic neuron loss and neuroinflammation. PARIS expression in the midbrain resulted in c-Abl activation, PARIS phosphorylation, MDM4 repression and p53 activation, all of which are blocked by the c-Abl inhibitor nilotinib. Importantly, we also observed aberrant c-Abl activation and PARIS phosphorylation along with PARIS accumulation in the midbrain of adult parkin knockout mice, implicating c-Abl in recessive Parkinson's disease. Inhibition of c-Abl or PARIS phosphorylation by nilotinib or Y137F-PARIS expression in adult parkin knockout mice blocked MDM4 repression and p53 activation, preventing motor deficits and dopaminergic neurodegeneration. Finally, we found correlative increases in PARIS phosphorylation, MDM4 repression and p53 activation in post-mortem Parkinson's disease brains, pointing to clinical relevance of the c-Abl-PARIS-MDM4-p53 pathway. Taken together, our results describe a novel mechanism of epigenetic regulation of dopaminergic degeneration downstream of pathological c-Abl activation in Parkinson's disease. Since c-Abl activation has been shown in sporadic Parkinson's disease, PARIS phosphorylation might serve as both a useful biomarker and a potential therapeutic target to regulate neuronal loss in Parkinson's disease.-
dc.language.isoen-
dc.subject.MESHAnimals-
dc.subject.MESHDopaminergic Neurons-
dc.subject.MESHHumans-
dc.subject.MESHMice-
dc.subject.MESHMice, Transgenic-
dc.subject.MESHNerve Degeneration-
dc.subject.MESHParkinsonian Disorders-
dc.subject.MESHPhosphorylation-
dc.subject.MESHProto-Oncogene Proteins c-abl-
dc.subject.MESHRepressor Proteins-
dc.titleParkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration-
dc.typeArticle-
dc.identifier.pmid34581802-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719843/-
dc.subject.keywordc-Abl-
dc.subject.keywordMDM4-
dc.subject.keywordp53-
dc.subject.keywordPARIS-
dc.subject.keywordParkinson's disease-
dc.contributor.affiliatedAuthorKang, HC-
dc.type.localJournal Papers-
dc.identifier.doi10.1093/brain/awab356-
dc.citation.titleBrain : a journal of neurology-
dc.citation.volume144-
dc.citation.number12-
dc.citation.date2021-
dc.citation.startPage3674-
dc.citation.endPage3691-
dc.identifier.bibliographicCitationBrain : a journal of neurology, 144(12). : 3674-3691, 2021-
dc.identifier.eissn1460-2156-
dc.relation.journalidJ000068950-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Physiology
Files in This Item:
34581802.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse